Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
Int J Infect Dis
; 96: 500-502, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-378227
ABSTRACT
No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen therapy, improved after treatment with nafamostat. These preliminary findings show the possibility that Nafamostat can be considered to be used in elderly patients with COVID-19 pneumonia who need oxygen therapy. The effectiveness of nafamostat should be evaluated in further studies.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Oxygen
/
Pneumonia, Viral
/
Coronavirus Infections
/
Betacoronavirus
/
Guanidines
Type of study:
Case report
/
Experimental Studies
/
Prognostic study
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2020
Document Type:
Article
Affiliation country:
J.ijid.2020.05.072
Similar
MEDLINE
...
LILACS
LIS